Invobenitug Also Known as Procizumab (PCZ; AK1967) in Critical Cardiovascular Care

Clinical trial NCT06832722 · RECRUITING

Trial details

NCT number: NCT06832722
Sponsor: 4TEEN4 Pharmaceuticals GmbH
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Shock, Cardiogenic

Start date: 2025-07-13
Primary completion: 2026-12-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.